Table 3.
Conditional logistic regression models for SARS-CoV-2 infection status in matched group (A) of SARS-CoV-2-positive patients with matched controls
Model | (1) | (2) | (3) | (4) | ||||
---|---|---|---|---|---|---|---|---|
Model Type | Univariable | Multivariable | ||||||
Explanatory variables | vitamin D ranges | vitamin D ranges + BMI | vitamin D ranges + BMI + ethnic group |
vitamin D ranges + BMI + ethnic group + comorbidity |
||||
OR (95% CI) | p value | OR (95% CI) | p value | OR (95% CI) | p value | OR (95% CI) | p value | |
Baseline vitamin D range | ||||||||
< 30 nmol/L | 1.442 (1.392–1.494) | < 0.001 | 1.364 (1.316–1.414) | < 0.001 | 1.253 (1.208–1.301) | < 0.001 | 1.246 (1.210, 1.304) | < 0.001 |
30–50 nmol/L | 1.333 (1.291–1.377) | < 0.001 | 1.272 (1.231–1.314) | < 0.001 | 1.215 (1.176–1.256) | < 0.001 | 1.211 (1.177, 1.258) | < 0.001 |
50–75 nmol/L | 1.128 (1.093–1.164) | < 0.001 | 1.099 (1.065–1.135) | < 0.001 | 1.091 (1.056–1.126) | < 0.001 | 1.091 (1.056, 1.126) | < 0.001 |
> 75 nmol/L | Ref. | Ref. | Ref. | Ref. | ||||
BMI category | ||||||||
< 25 kg/m2 | Ref. | Ref. | Ref. | |||||
25–30 kg/m2 | 1.198 (1.167–1.229) | < 0.001 | 1.189 (1.158–1.220) | < 0.001 | 1.182 (1.152–1.213) | < 0.001 | ||
30–35 kg/m2 | 1.407 (1.365–1.451) | < 0.001 | 1.384 (1.343–1.427) | < 0.001 | 1.360 (1.319–1.403) | < 0.001 | ||
> 35 kg/m2 | 1.471 (1.418–1.526) | < 0.001 | 1.449 (1.397–1.503) | < 0.001 | 1.406 (1.354–1.460) | < 0.001 | ||
Ethnic group | ||||||||
General population | Ref. | Ref. | ||||||
Ultra-orthodox | 2.834 (2.732–2.940) | < 0.001 | 2.841 (2.739–2.948) | < 0.001 | ||||
Arab | 1.571 (1.518–1.625) | < 0.001 | 1.558 (1.505–1.612) | < 0.001 | ||||
Comorbidity | ||||||||
Arrhythmia | 1.088 (1.036–1.143) | 0.001 | ||||||
Asthma | 1.007 (0.963–1.053) | 0.753 | ||||||
CHF | 1.125 (1.048–1.208) | 0.002 | ||||||
COPD | 0.929 (0.867–0.996) | 0.038 | ||||||
Chronic Renal Failure | 1.154 (1.091–1.222) | < 0.001 | ||||||
Diabetes Mellitus | 1.120 (1.086–1.156) | < 0.001 | ||||||
Hypertension | 1.010 (0.978–1.044) | 0.544 | ||||||
IHD | 0.988 (0.944–1.034) | 0.599 | ||||||
Malignancy | 0.932 (0.896–0.969) | < 0.001 |
OR odds ratio, CI confidence Interval, BMI body mass index, CHF congestive heart failure, COPD chronic obstructive pulmonary disease, IHD ischemic heart disease, ref. reference